Managing malignant sublingual gland tumors: a single institution experience with 23 patients.
Pathological types
Primary malignant sublingual gland tumors
Soft tissue reconstruction
Surgical excision prognosis
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
11 Sep 2024
11 Sep 2024
Historique:
received:
11
06
2024
accepted:
03
09
2024
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
11
9
2024
Statut:
epublish
Résumé
Due to the relative rarity of malignant sublingual gland tumors, diagnosing and treating them clinically pose challenges. Hence, there's a need to explore the pathological types, characteristics, treatment methods, and prognosis of primary malignant tumors of the sublingual gland to improve our understanding and management of these rare yet highly malignant conditions. This study reviewed cases of primary malignant sublingual gland tumors, analyzing their characteristics. The treatment methods included surgical excision, with additional radiotherapy, or brachytherapy for advanced stages or positive surgical margins. The study also summarized different treatment approaches, including lymph node dissection and soft tissue reconstruction using free flaps such as the anterolateral thigh flap and forearm flap. We have gathered 23 cases of sublingual gland malignancies treated at the Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, from January 2013 to May 2024. The most common pathological types were adenoid cystic carcinoma and mucoepidermoid carcinoma, with rare cases of mucosa-associated lymphoid tissue (MALT) lymphoma and nonspecific salivary gland clear cell carcinoma. Early diagnosis and surgical intervention were crucial for a favorable prognosis. Marginal mandibulectomy was necessary for cases involving the mandible. Patients with positive preoperative lymph node detection required cervical lymph node dissection. Extensive tissue defects in the floor of the mouth were effectively reconstructed with free flaps to prevent oral-mandibular fistula. Surgical excision remains the preferred treatment for malignant sublingual gland tumors. Early diagnosis and comprehensive surgical management are essential for improving prognosis. The study's limitations include a small sample size and short follow-up duration, necessitating further research with larger clinical samples to confirm these findings.
Sections du résumé
BACKGROUND
BACKGROUND
Due to the relative rarity of malignant sublingual gland tumors, diagnosing and treating them clinically pose challenges. Hence, there's a need to explore the pathological types, characteristics, treatment methods, and prognosis of primary malignant tumors of the sublingual gland to improve our understanding and management of these rare yet highly malignant conditions.
METHODS
METHODS
This study reviewed cases of primary malignant sublingual gland tumors, analyzing their characteristics. The treatment methods included surgical excision, with additional radiotherapy, or brachytherapy for advanced stages or positive surgical margins. The study also summarized different treatment approaches, including lymph node dissection and soft tissue reconstruction using free flaps such as the anterolateral thigh flap and forearm flap.
RESULTS
RESULTS
We have gathered 23 cases of sublingual gland malignancies treated at the Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, from January 2013 to May 2024. The most common pathological types were adenoid cystic carcinoma and mucoepidermoid carcinoma, with rare cases of mucosa-associated lymphoid tissue (MALT) lymphoma and nonspecific salivary gland clear cell carcinoma. Early diagnosis and surgical intervention were crucial for a favorable prognosis. Marginal mandibulectomy was necessary for cases involving the mandible. Patients with positive preoperative lymph node detection required cervical lymph node dissection. Extensive tissue defects in the floor of the mouth were effectively reconstructed with free flaps to prevent oral-mandibular fistula.
CONCLUSION
CONCLUSIONS
Surgical excision remains the preferred treatment for malignant sublingual gland tumors. Early diagnosis and comprehensive surgical management are essential for improving prognosis. The study's limitations include a small sample size and short follow-up duration, necessitating further research with larger clinical samples to confirm these findings.
Identifiants
pubmed: 39261773
doi: 10.1186/s12885-024-12899-y
pii: 10.1186/s12885-024-12899-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1135Subventions
Organisme : Beijing Xi sike Clinical Oncology Research Foundation
ID : Y-HR2022MS-0452
Organisme : Beijing Xi sike Clinical Oncology Research Foundation
ID : Y-HR2022QN-0515
Informations de copyright
© 2024. The Author(s).
Références
Board WCTE. Head and neck tumours. In: WHO Classif Tumours Ser Volume 9, 5 edn.; 2024.
Mantravadi AV, Moore MG, Rassekh CH. AHNS series: do you know your guidelines? Diagnosis and management of salivary gland tumors. Head Neck. 2019;41(2):269–80.
doi: 10.1002/hed.25499
pubmed: 30548929
Rinaldo A, Shaha AR, Pellitteri PK, Bradley PJ, Ferlito A. Management of malignant sublingual salivary gland tumors. Oral Oncol. 2004;40(1):2–5.
doi: 10.1016/S1368-8375(03)00104-0
pubmed: 14662408
Green B, Rahimi S, Brennan PA. Salivary gland malignancies - an update on current management for oral healthcare practitioners. Oral Dis. 2016;22(8):735–9.
doi: 10.1111/odi.12498
pubmed: 27133450
Gontarz M, Urbańska-Gąsiorowska M, Bargiel J, Gąsiorowski K, Marecik T, Szczurowski P, Zapała J, Wyszyńska-Pawelec G. Sublingual gland neoplasms: clinicopathological study of 8 cases. Med oral Patologia oral y Cir Bucal. 2021;26(5):e626–31.
doi: 10.4317/medoral.24634
Park W, Park M, Choi K, Heo Y, Choi SY, Cho J, Ko YH, Jeong HS. Analysis of local invasion and regional spread in malignant sublingual gland tumour: implications for surgical planning. Int J Oral Maxillofac Surg. 2021;50(10):1280–8.
doi: 10.1016/j.ijom.2021.01.016
pubmed: 33602646
Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M Jr., Takes RP, et al. Adenoid cystic carcinoma of the head and neck–An update. Oral Oncol. 2015;51(7):652–61.
doi: 10.1016/j.oraloncology.2015.04.005
pubmed: 25943783
Peraza A, Gómez R, Beltran J, Amarista FJ. Mucoepidermoid carcinoma. An update and review of the literature. J Stomatol Oral Maxillofac Surg. 2020;121(6):713–20.
doi: 10.1016/j.jormas.2020.06.003
pubmed: 32565266
Zhang SL, Ma SR, Mao L, Yu ZL, Jia J. One case of sublingual gland mucosa-associated lymphoid tissue lymphoma. Oral Oncol. 2024;148:106648.
doi: 10.1016/j.oraloncology.2023.106648
pubmed: 38006689
Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Cancer J Clin. 2016;66(2):153–71.
doi: 10.3322/caac.21330
Kiesewetter B, Ferreri AJ, Raderer M. Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: a review of the literature. Oncologist. 2015;20(8):915–25.
doi: 10.1634/theoncologist.2015-0109
pubmed: 26156327
pmcid: 4524756
Weinreb I. Hyalinizing clear cell carcinoma of salivary gland: a review and update. Head Neck Pathol. 2013;7(Suppl 1):S20–29.
doi: 10.1007/s12105-013-0466-8
pubmed: 23821218
Ferrell JK, Mace JC, Clayburgh D. Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review. Eur Arch Otorhinolaryngol. 2019;276(4):1135–46.
doi: 10.1007/s00405-019-05282-2
pubmed: 30649610
DeAngelis AF, Tsui A, Wiesenfeld D, Chandu A. Outcomes of patients with adenoid cystic carcinoma of the minor salivary glands. Int J Oral Maxillofac Surg. 2011;40(7):710–4.
doi: 10.1016/j.ijom.2011.02.010
pubmed: 21396798
Huang TT, Chou YF, Wen YH, Chen PR. Resected tumours of the sublingual gland: 15 years’ experience. Br J Oral Maxillofac Surg. 2016;54(6):625–8.
doi: 10.1016/j.bjoms.2016.03.014
pubmed: 27062437
Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, et al. NCCN Guidelines
doi: 10.6004/jnccn.2022.0016
pubmed: 35276673
Park M, Cho J, Ryu J, Jeong HS. Diagnosis and management of malignant sublingual gland tumors: a narrative review. Gland Surg. 2021;10(12):3415–23.
doi: 10.21037/gs-21-620
pubmed: 35070901
pmcid: 8749102
Wu Y, Lu H, Liu L, Zhu Y, Zhang X, Xu W, Liu S, Yang W. Malignant sublingual gland tumors: a single-center retrospective analysis of 79 patients. Oral Dis. 2024;30(3):1209–19.
doi: 10.1111/odi.14538
pubmed: 36794916
Zhang SL, Xu N, Bo Dou C, Mao L, Ma SR, Jia J, Yu ZL. Reconstructive strategies following surgical resection of malignant sublingual gland tumors: a single institution experience. J Stomatol Oral Maxillofac Surg 2024:101908.
Jie Z, Jian M, Qianwei Z, Zhiping L. Dosimetry study on radioactive particle brachytherapy in oral carcinoma. J BUON: Official J Balkan Union Oncol. 2017;22(2):519–23.
Zhang HY, Shao Z, Jia J, Liu B, Bu LL. Analysis of intraoral microvascular anastomosis in maxillofacial defects reconstruction. J Craniomaxillofac Surg. 2023;51(1):31–43.
doi: 10.1016/j.jcms.2023.01.008
pubmed: 36725484
Joseph ST, Naveen BS, Mohan TM. Islanded facial artery musculomucosal flap for tongue reconstruction. Int J Oral Maxillofac Surg. 2017;46(4):453–5.
doi: 10.1016/j.ijom.2016.11.010
pubmed: 28011124